Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
BCBS Federal Employee Program (FEP) Medical Policy Updates – April 2018
April 2018 Medical Policy Updates:
- Artificial Pancreas Device Systems
- Prolotherapy
- Cooling Devices Used in the Outpatient Setting
- Transcutaneous Electrical Nerve Stimulation
- Noncontact Ultrasound Treatment for Wounds
- Transanal Radiofrequency Treatment of Fecal Incontinence
- Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease
- Hyperbaric Oxygen Therapy
- Ingestible pH and Pressure Capsule
- Nonpharmacologic Treatment of Rosacea
- Bioimpedance Devices for Detection and Management of Lymphedema
- Chromoendoscopy as an Adjunct to Colonoscopy
- Confocal Laser Endomicroscopy
- Laser Treatment of Onychomycosis
- Peroral Endoscopic Myotomy for Treatment of Esophageal Achalasia
- Cerebrospinal Fluid and Urinary Biomarkers of Alzheimer Disease
- Closure Devices for Patent Foramen Ovale and Atrial Septal Defects
- Epidural Steroid Injections for Back Pain
- Identification of Microorganisms Using Nucleic Acid Probes
- Analysis of Human DNA in Stool Samples as a Technique for Colorectal Cancer Screening
- Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
- Measurement of Lipoprotein-Associated Phospholipase A2 in the Assessment of Cardiovascular Risk
- Pharmacogenomic and Metabolite Markers for Patients Treated With Thiopurines
- Immune Cell Function Assay
- Noninvasive Techniques for the Evaluation and Monitoring of Patients With Chronic Liver Disease
- KRAS, NRAS, and BRAF Variant Analysis in Metastatic Colorectal Cancer
- Genetic and Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate Cancer
- Laboratory Testing for HIV Tropism
- Serum Biomarker Human Epididymis Protein 4
- Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients With Breast Cancer
- Genetic Testing for Cardiac Ion Channelopathies
- Genetic Testing for Developmental Delay/Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies
- Multimarker Serum Testing Related to Ovarian Cancer
- Measurement of Serum Antibodies to Infliximab and Adalimumab
- DNA-Based Testing for Adolescent Idiopathic Scoliosis
- Genetic Testing for Alpha1-Antitrypsin Deficiency
- Genetic Testing for FMR1 Variants (Including Fragile X Syndrome)
- Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathies
- Quantitative Assay for Measurement of HER2 Total Protein Expression and HER2 Dimers
- Genetic Testing for Statin-Induced Myopathy
- Genetic Testing for Neurofibromatosis
- Genetic Testing for FLT3, NPM1, and CEBPA Variants in Cytogenetically Normal Acute Myeloid Leukemia
- Proteomic Testing for Targeted Therapy in Non-Small-Cell Lung Cancer
- Cardiovascular Risk Panels
- Circulating Tumor DNA for Management of Non-Small-Cell Lung
- Drug Testing in Pain Management and Substance Use Disorder Treatment
- Gene Expression Profiling and Protein Biomarkers for Prostate Cancer Management
- Nutrient/Nutritional Panel Testing
- Autologous Chondrocyte Implantation for Focal Articular Cartilage Lesions
- Cryosurgical Ablation of Miscellaneous Solid Tumors Other Than Liver, Prostate, or Dermatologic Tumors
- Facet Joint Denervation
- Noninvasive Prenatal Screening for Fetal Aneuploidies and Microdeletions Using Cell-Free Fetal DNA
- Percutaneous Intradiscal Electrothermal Annuloplasty, Radiofrequency Annuloplasty, and Biacuplasty
- Plugs for Anal Fistula Repair
- Wireless Capsule Endoscopy to Diagnose Disorders of the Small Bowel, Esophagus, and Colon
- Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease
- Transanal Endoscopic Microsurgery
- Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast
- Amniotic Membrane and Amniotic Fluid
- Prostatic Urethral Lift
- Balloon Dilation of the Eustachian Tube
- Intraoperative Radiotherapy
- Synthetic Cartilage Implants for Joint Pain
- Chemical Peels
- Lysis of Epidural Adhesions
- Orthopedic Applications of Stem Cell Therapy (Including Allografts and Bone Substitutes Used With Autologous Bone Marrow)
- Treatment of Tinnitus
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
